Alex Wyke

Marketing

ViiV, Gilead and Janssen notch top scores with HIV/AIDS groups

Only half of the 168 HIV/AIDS patient groups polled in a new survey rated pharma's overall reputation "excellent" or "good."
Natalie Missakian Jun 22, 2022 9:35am

GSK's ViiV, Pfizer and Roche score high with patient groups

Apr 27, 2022 3:24am

Roche, Takeda, Pfizer rank highest with rare disease patients

Oct 4, 2021 9:15am

Roche, Pfizer, Novartis earn top 2020 marks from cancer patients

Jun 7, 2021 3:45am

U.S. patient groups might just be warming up to pharma

May 14, 2018 9:30am

Pharma's rep with patient groups drops again

Mar 21, 2017 9:53am